Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acid-promoted
4%
Activator protein-1 (AP-1)
9%
Bile Acid Metabolism
4%
Bile Duct Ligation
4%
Biliary Cancer
4%
C-Maf
4%
C-Myc
9%
Cancer Cell Growth
4%
Cancer Cell Lines
4%
Cancer Cell Proliferation
4%
Changes in Gene Expression
4%
China
4%
Cholangiocarcinoma
14%
Cholestasis
14%
Cholestatic Liver Disease
100%
Chromatin Immunoprecipitation (ChIP)
4%
Clinical Data
4%
Diethylnitrosamine
9%
Distinct Mechanism
9%
Dysregulation
100%
E-box
4%
E-box Element
4%
Electrophoretic Mobility Shift
4%
Expression Activity
4%
Expression Level
4%
Farnesoid X Receptor
14%
Hep3B Cells
4%
Hepatitis B
4%
Hepatocellular Carcinoma
14%
HepG2
4%
HepG2 Cells
4%
High-level Expression
4%
Human Cholangiocarcinoma
9%
Human Hepatocellular Carcinoma
4%
Human Liver Cancer
4%
Immunoblot
4%
Immunohistochemistry
4%
Increased Activity
4%
Incubation
4%
Knockdown
4%
Liver Cancer
100%
Liver Development
100%
Liver Tumor
9%
MAT1A
23%
Microvascular Invasion
4%
Non-tumor Tissue
14%
Nuclear factor-B
9%
Nude Mice
4%
Opposite Effects
4%
Overexpression
4%
Promoter Activity
9%
Promoter Region
4%
Quantitative PCR
4%
Reduced Expression
9%
Reduced Survival
4%
S-adenosylmethionine
19%
S-adenosylmethionine Decarboxylase
4%
Short-term Survival
4%
Small Interfering RNA (siRNA)
4%
Surgical Resection
4%
Survival Time
9%
Tauroursodeoxycholic Acid (TUDCA)
19%
Transcription Factor
100%
Transient Transfection
4%
Tumor Growth
4%
Tumor Progression
4%
Xenograft Tumor
14%
Medicine and Dentistry
Bile Acid Synthesis
4%
Bile Duct Cancer
4%
Bile Duct Ligation
4%
Cancer Cell
4%
Cancer Cell Line
4%
Cell Growth
4%
Cell Proliferation
4%
Cholangiocarcinoma
28%
Cholestasis
14%
Chromatin Immunoprecipitation
4%
Diethylnitrosamine
9%
Electrophoretic Mobility-Shift Assay
4%
Farnesoid X Receptor
14%
Gene Expression
4%
Hepatitis B
4%
Hepatocellular Carcinoma
19%
Immunoblotting
4%
Immunohistochemistry
4%
Incubation
4%
Lithocholic Acid
4%
Liver Cancer
100%
Liver Development
100%
Liver Injury
100%
Liver Tumor
9%
Methionine Adenosyltransferase
4%
Neoplasm
14%
Promoter Region
23%
Real Time Polymerase Chain Reaction
4%
S-Adenosyl Methionine
19%
Small Interfering RNA
4%
Survival Time
9%
Transcription Factor AP 1
9%
Transcription Factors
100%
Transient Transfection
4%
Tumor Progression
9%
Tumor Xenograft
14%
Upregulation
4%
Ursodeoxycholic Acid
19%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Acid
4%
Bile Duct Carcinoma
28%
Cholestasis
14%
Chromatin Immunoprecipitation
4%
Diethylnitrosamine
9%
Farnesoid X Receptor
14%
Hepatitis B
4%
Lithocholic Acid
4%
Liver Cancer
100%
Liver Cell Carcinoma
19%
Liver Injury
100%
Liver Tumor
9%
Malignant Neoplasm
4%
Neoplasm
14%
Nude Mouse
4%
Receptor Agonist
9%
S-Adenosyl Methionine
19%
Small Interfering RNA
4%
Survival Time
9%
Transcription Factor AP 1
9%
Transcription Factors
100%
Tumor Growth
9%
Western Blot
4%
Biochemistry, Genetics and Molecular Biology
AP-1 Transcription Factor
9%
Bile Acid Synthesis
4%
Cancer Cell
9%
Cell Growth
4%
Cell Proliferation
4%
Chromatin Immunoprecipitation
4%
E Box Element
9%
Electrophoretic Mobility-Shift Assay
4%
Expression Level
4%
Farnesoid X Receptor
14%
Gene Expression
4%
Immunoblotting
4%
Methionine
4%
Nude Mouse
4%
Pribnow Box
4%
Promoter Region
19%
Real-Time Polymerase Chain Reaction
4%
Receptor Agonists
9%
S-Adenosyl Methionine
19%
Small Interfering RNA
4%
Survival Time
9%
Transcription
4%
Transcription Factors
100%
Transient Transfection
4%
Tumor Progression
9%
Upregulation
4%
Ursodeoxycholic Acid
19%